[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019

December 2019 | 164 pages | ID: D65175B1C578EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019' provides an overview of Deep Brain Stimulators (DBS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators (DBS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Deep Brain Stimulators (DBS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Deep Brain Stimulators (DBS) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

4 DEEP BRAIN STIMULATORS (DBS) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development

5 DEEP BRAIN STIMULATORS (DBS) COMPANIES AND PRODUCT OVERVIEW

5.1 Adaptive Neuromodulation GmbH Company Overview
  5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adept Neuro SA Company Overview
  5.2.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aleva Neurotherapeutics SA Company Overview
  5.3.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Baylor College of Medicine Company Overview
  5.4.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.5 Bioinduction Limited Company Overview
  5.5.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
5.6 Boston Scientific Corp Company Overview
  5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 Brainsway Ltd Company Overview
  5.7.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cleveland Medical Devices Inc Company Overview
  5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Clinatec Company Overview
  5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cortera Neurotechnologies Inc Company Overview
  5.10.1 Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Deep Brain Innovations, LLC Company Overview
  5.11.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Enspire DBS Therapy Inc Company Overview
  5.12.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Functional Neuromodulation Inc. Company Overview
  5.13.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Louisiana State University Company Overview
  5.14.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Massachusetts General Hospital Company Overview
  5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.16 Massachusetts Institute of Technology Company Overview
  5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.17 Medtronic plc Company Overview
  5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.18 National Cheng-Kung University Hospital Company Overview
  5.18.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.19 NeuroOne Inc Company Overview
  5.19.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Neuroparticle Corp Company Overview
  5.20.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview
5.21 NeuroPro Technologies Inc Company Overview
  5.21.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Neurosigma Inc Company Overview
  5.22.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Newronika s.r.l. Company Overview
  5.23.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.24 Nexeon MedSystems Inc Company Overview
  5.24.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.26 St. Jude Medical LLC Company Overview
  5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 Sunnybrook Health Sciences Centre Company Overview
  5.27.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview
5.28 SUNY Downstate Medical Center Company Overview
  5.28.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of California Los Angeles Company Overview
  5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Central Florida Company Overview
  5.30.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Florida Company Overview
  5.31.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Houston Company Overview
  5.32.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview
5.33 University of Illinois Company Overview
  5.33.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
5.34 University of Milan Company Overview
  5.34.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview
5.35 University of Minnesota Company Overview
  5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.36 University of Oxford Company Overview
  5.36.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Rochester Company Overview
  5.37.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of South Florida Company Overview
  5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.39 Wedge Therapeutics Company Overview
  5.39.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

6 DEEP BRAIN STIMULATORS (DBS)- RECENT DEVELOPMENTS

6.1 Nov 25, 2019: BrainsWay reports third quarter 2019 financial results and operational highlights
6.2 Nov 25, 2019: BrainsWay appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer
6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
6.5 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Table 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Table 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Table 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Table 6: Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Table 7: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CR-Capable Implant - Product Status
Table 10: CR-Capable Implant - Product Description
Table 11: Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Stereo-Electro-Encephalo-Graphie Electrode - Product Status
Table 13: Stereo-Electro-Encephalo-Graphie Electrode - Product Description
Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: directSTIM - Product Status
Table 16: directSTIM - Product Description
Table 17: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Adaptive Deep Brain Stimulation (aDBS) Device - Product Status
Table 19: Adaptive Deep Brain Stimulation (aDBS) Device - Product Description
Table 20: Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Picostim - Product Status
Table 22: Picostim - Product Description
Table 23: Bioinduction Limited - Ongoing Clinical Trials Overview
Table 24: Picostim - Simpler and Safer Deep Brain Stimulation for Parkinson's Disease
Table 25: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
Table 27: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
Table 28: Next Generation DBS System - Product Status
Table 29: Next Generation DBS System - Product Description
Table 30: Vercise Deep Brain Stimulation System - Dystonia - Product Status
Table 31: Vercise Deep Brain Stimulation System - Dystonia - Product Description
Table 32: Vercise Deep Brain Stimulation System - Tremors - Product Status
Table 33: Vercise Deep Brain Stimulation System - Tremors - Product Description
Table 34: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 35: Vercise Deep Brain Stimulation System - Dystonia - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Table 36: Vercise Deep Brain Stimulation System - Dystonia - Registry of Deep Brain Stimulation with the Vercise System for Treatment of Dystonia: Vercise DBS Dystonia Registry
Table 37: Vercise Deep Brain Stimulation System - Dystonia - Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
Table 38: Vercise Deep Brain Stimulation System - Tremors - Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET): ET Registry
Table 39: Vercise Deep Brain Stimulation System - Tremors - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Table 40: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Deep TMS System - Alzheimer's Disease - Product Status
Table 42: Deep TMS System - Alzheimer's Disease - Product Description
Table 43: Deep TMS System - Bipolar Disorder - Product Status
Table 44: Deep TMS System - Bipolar Disorder - Product Description
Table 45: Deep TMS System - PTSD - Product Status
Table 46: Deep TMS System - PTSD - Product Description
Table 47: Deep TMS System - Smoking Cessation - Product Status
Table 48: Deep TMS System - Smoking Cessation - Product Description
Table 49: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Status
Table 50: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Description
Table 51: Brainsway Ltd - Ongoing Clinical Trials Overview
Table 52: Deep TMS System - Bipolar Disorder - A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression
Table 53: Deep TMS System - PTSD - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-traumatic Stress Disorder (PTSD)
Table 54: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: ParkinTune - Product Status
Table 56: ParkinTune - Product Description
Table 57: Clinatec Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Intracranial Deep Brain Stimulation Device - Product Status
Table 59: Intracranial Deep Brain Stimulation Device - Product Description
Table 60: Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: WAND - Product Status
Table 62: WAND - Product Description
Table 63: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 64: TOPS Device - Alzheimer's disease - Product Status
Table 65: TOPS Device - Alzheimer's disease - Product Description
Table 66: TOPS Device - Depression - Product Status
Table 67: TOPS Device - Depression - Product Description
Table 68: TOPS Device - Epilepsy - Product Status
Table 69: TOPS Device - Epilepsy - Product Description
Table 70: TOPS Device - Obesity - Product Status
Table 71: TOPS Device - Obesity - Product Description

LIST OF FIGURES

Figure 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Figure 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Figure 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Figure 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Figure 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

COMPANIES MENTIONED

Adaptive Neuromodulation GmbH
Adept Neuro SA
Aleva Neurotherapeutics SA
Baylor College of Medicine
Bioinduction Limited
Boston Scientific Corp
Brainsway Ltd
Cleveland Medical Devices Inc
Clinatec
Cortera Neurotechnologies Inc
Deep Brain Innovations, LLC
Enspire DBS Therapy Inc
Functional Neuromodulation Inc.
Louisiana State University
Massachusetts General Hospital
Massachusetts Institute of Technology
Medtronic plc
National Cheng-Kung University Hospital
NeuroOne Inc
Neuroparticle Corp
NeuroPro Technologies Inc
Neurosigma Inc
Newronika s.r.l.
Nexeon MedSystems Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Sunnybrook Health Sciences Centre
SUNY Downstate Medical Center
University of California Los Angeles
University of Central Florida
University of Florida
University of Houston
University of Illinois
University of Milan
University of Minnesota
University of Oxford
University of Rochester
University of South Florida
Wedge Therapeutics


More Publications